Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Sepsis-Associated Acute Kidney Injury

Pathophysiology and Clinical Presentation

  • The metabolic hallmark of AKI in sepsis includes protein catabolism, altered amino acid metabolism, peripheral insulin resistance, and impaired lipid clearance, typically resulting in metabolic acidosis 1, 2
  • Tissue hypoperfusion leads to lactic acidosis, a common acid-base disturbance in sepsis-associated AKI 3
  • Impaired renal acid excretion due to kidney dysfunction contributes to metabolic acidosis in sepsis-associated AKI 4
  • Inflammatory mediators affect cellular metabolism, leading to metabolic derangements and acidosis in sepsis-associated AKI 5

Management and Treatment

  • The KDIGO guidelines address the management of metabolic acidosis in AKI, indicating its prevalence in this condition 4, 6
  • The Surviving Sepsis Campaign guidelines recommend against the use of sodium bicarbonate therapy for hypoperfusion-induced lactic acidemia with pH ≥ 7.15 3
  • Management of sepsis-associated AKI should focus on treating the underlying sepsis with appropriate antimicrobials, maintaining adequate renal perfusion, and using crystalloids rather than colloids for fluid resuscitation 3, 4
  • Renal replacement therapy should be considered for severe metabolic derangements in sepsis-associated AKI 3

Monitoring and Prevention

  • Regular monitoring of acid-base status is essential in patients with sepsis-associated AKI 3
  • Prevention strategies should focus on early recognition and treatment of sepsis, avoiding nephrotoxic medications, maintaining adequate renal perfusion, and appropriate fluid management to prevent both hypovolemia and fluid overload 4, 7